- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06280183
Functional Inspiratory Muscle Training in Obese Individuals
The Investigation of the Effects of Functional Inspiratory Muscle Training in Obese Individuals
In obese individuals, increased adipose tissue and systemic inflammation play a key role in the development of cardiometabolic diseases, pulmonary system dysfunction, and many respiratory diseases. Existing research has demonstrated beneficial clinical outcomes of inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals. However, this focused on the isolated effects of exercise on obesity. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals.
This study aims to investigate the effects of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength, and respiratory muscle performance in obese individuals.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obesity is characterized by increased adipose tissue and systemic inflammation that play a key role in the development of non-communicable chronic diseases. It is well known that individuals with obesity have decreased exercise capacity and muscle weakness in both peripheral and respiratory muscles.
Exercise training is recommended in addition to healthy dietary habits in managing obesity. Current literature demonstrated beneficial clinical outcomes of isolated inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals.
Functional inspiratory muscle training is a method that combines both aerobic exercise and inspiratory muscle training. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals. The aim of this study is to investigate the effect of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength and respiratory muscle performance in obese individuals.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Biruni University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Those between the ages of 25-60
- According to the World Health Organization (WHO) classification, those with a body mass index between 30-40 kg/m2
- Volunteering to participate in the research
Exclusion Criteria:
- According to the World Health Organization (WHO) classification, body mass index is over 40 kg/m2
- Functional class III or IV according to the New York Heart Association (NYHA) classification
- Those with a Charlson comorbidity score of 3 and above
- Uncontrolled hypertension, diabetes and unstable angina pectoris
- Cooperative disorders, orthopedic and neurological problems that may interfere with evaluation and treatment
- Individuals with a history of lower extremity-related injury or surgery in the last six months
- Being diagnosed with diabetes and having complications such as nephropathy, retinopathy and neuropathy
- Those with accompanying chronic respiratory disease
- Those with acute infection
- Individuals with middle ear-related pathologies (such as tympanic membrane rupture, otitis)
- Those with a STOP-Bang score of 3 and above
- Individuals with a history of spontaneous or trauma-related pneumothorax
- Smokers
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Aerobic and Resistive Exercise Training
The exercise program will start with a 5-10 minute warm-up and end with a 5-10 minute cool down. Aerobic exercise is planned at 60-85% of Maximum Heart Rate on the bike for 30-40 minutes. Resistive exercise program, covering all major major muscle groups; The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen. For upper body muscles, abdominal muscles and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1 maximum repetition (1RM). |
Aerobic exercise is planned at 60-85% of the Maximum Heart Rate on a cycle ergometer for 30-40 minutes.
Resistive exercise will cover all major muscle groups.
The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles, and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen.
For upper body, abdominal, and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1 maximum repetition (1RM).
|
|
Experimental: Functional Inspiratory Muscle Training Group in obese individuals:
Inspiratory muscle training will be applied simultaneously with aerobic exercise.
This program will create the functional IMT.
The exercise program will start with a 5-10 minute warm-up and cool down.
Aerobic exercise is planned at 60-85% of MHR on the bike for 30-40 minutes, progress will be achieved.
Participants will first work with bicycle ergometry and then continue with IMT in the same session for the first three weeks.
The intensity of IMT exercise will be set at 40-60% of MIP.
After 10 consecutive breathing cycles, participants will be asked to perform 3-4 breath checks.
Resistive exercise program, covering all major muscle groups; The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen.
For upper body muscles, abdominal muscles and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1RM.
|
Inspiratory muscle training is a technique that combines aerobic training with inspiratory muscle training.
will be applied simultaneously with aerobic exercise.
Participants will work with bicycle ergometry and then continue with IMT in the same session for the first three weeks.
The intensity of IMT exercise will be set at 40-60% of MIP.
|
|
No Intervention: Control Group:
Patient education will be given and no intervention will be made.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Capacity
Time Frame: 10 weeks
|
Submaximal functional exercise capacity of the participants will be evaluated with six- minute walk test.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comorbidity Assessment
Time Frame: Day 1
|
"Charlson Comorbidity Index" (CMI) will be used to determine the comorbidity levels of obese individuals.
The index, which consists of nineteen comorbid diagnosis groups, is a valid method for evaluating chronic diseases and measuring their relationship with mortality.
All CMI scores are scored between 0-37.
According to the results, 3 levels of comorbidity are defined: low (0), medium (1-2) and high (3+).
|
Day 1
|
|
Physical Activity Assessment
Time Frame: 10 weeks
|
Step Count Measurement: Daily step count will be monitored to determine the physical activity level of the participants.
Step count will be assessed with a wearable activity monitor, a portable, easy-to-use tool that can measure objectively (Huawei Watch Fit Special Edition).
With its six-axis sensor, the device records the user's physical activity style information in its temporary memory throughout the duration of use.
Participants will be asked to wear the activity monitor on their left wrist throughout and only remove it during bathing.
After one week of use, the data recorded with the wearable activity monitor will be taken.
|
10 weeks
|
|
Edmonton Obesity Staging System (EOSS)
Time Frame: Day 1
|
The Edmonton Obesity Staging System (EOSS) is a five-stage obesity classification system used to determine prognosis and guide treatment when assessing obesity-related risk.
|
Day 1
|
|
Peripheral Muscle Strength
Time Frame: 10 weeks
|
M. Quadriceps muscle strength and hand grip strength measurement will be used to evaluate peripheral muscle strength.
Hand-held dynamometer will be used to evaluate quadriceps muscle strength and hand grip strength.
|
10 weeks
|
|
Waist circumference
Time Frame: 10 weeks
|
Waist circumference will be measured at belly level with the patient in an upright position during expiration, with both feet bearing equal weight.
|
10 weeks
|
|
Hip circumference
Time Frame: 10 weeks
|
Hip circumference will be measured at the level of the greater femoral trochanter, with the patient in an upright position, with both feet bearing equal weight.
|
10 weeks
|
|
Body fat-muscle ratios
Time Frame: 10 weeks
|
These measurements will be determined by bioelectrical impedance.
|
10 weeks
|
|
Glucose profile
Time Frame: 10 weeks
|
Glucose profile after 12 hours of fasting will be measured
|
10 weeks
|
|
Lipid profile
Time Frame: 10 weeks
|
Lipid profile after 12 hours of fasting will be measured
|
10 weeks
|
|
Respiratory Muscle Strength
Time Frame: 10 weeks
|
Respiratory muscle strength; it will be evaluated with an intraoral pressure measuring device in a sitting position.
|
10 weeks
|
|
Incremental load test (Respiratory muscle endurance)
Time Frame: 10 weeks
|
Respiratory muscle endurance will be evaluated by incremental load test.
The incremental load test will be performed using the electronic inspiratory loading device (PowerBreathe-KHP2)
|
10 weeks
|
|
Forced expiratory volume 1st second (Respiratory function)
Time Frame: 10 weeks
|
Spirometric assessment will be performed to determine participants' forced expiratory volume in one second (FECV1).
|
10 weeks
|
|
Forced vital capacity (Respiratory function)
Time Frame: 10 weeks
|
Spirometric assessment will be performed to determine participants' forced vital capacity (FVC)
|
10 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Buket Akinci, Assoc. Prof., Biruni University
- Study Director: Alihan Oral, Assoc. Prof., Biruni University Hospital
- Principal Investigator: Safak Yigit, MSc, Biruni University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 323132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Aerobic+Resistive Exercise Traning
-
Cairo UniversityCompletedAcute Myeloid Leukemia in RemissionEgypt
-
Yeditepe UniversityCompleted
-
Cairo UniversityNot yet recruitingHemodialysis ComplicationEgypt
-
Baltimore VA Medical CenterActive, not recruitingCancer, Breast | Cancer, Lung | Cancer, Ovarian | Cancer, ColorectalUnited States
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Cairo UniversityRecruitingAerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis PatientsChronic Kidney Disease Requiring HemodialysisEgypt
-
Loughborough UniversityActive, not recruitingDementia | Mild Cognitive Impairment | Older AdultsUnited Kingdom
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
Acibadem UniversityCompleted